trending Market Intelligence /marketintelligence/en/news-insights/trending/l_NYIPKccxc5n8ZOF4xsxA2 content esgSubNav
In This List

Lupin receives FDA approval to market generic antidepressant drug

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Lupin receives FDA approval to market generic antidepressant drug

India-based Lupin Ltd. received U.S. FDA approval to market its Paroxetin extended release tablets, a generic of Apotex Technologies Inc.'s Paxil CR tablets.

The drug is indicated for the treatment of major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder.

Lupin will begin promoting the product soon.